613
Views
3
CrossRef citations to date
0
Altmetric
REVIEW

Usage of Glucagon-Like Peptide-1 for Obesity in Children; Updated Review of Clinicaltrials.gov

ORCID Icon & ORCID Icon
Pages 2179-2187 | Received 16 May 2023, Accepted 07 Jul 2023, Published online: 31 Jul 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Omar E Hegazi, Samer O Alalalmeh, Moyad Shahwan, Ammar Abdulrahman Jairoun, Mansour M Alourfi, Ghfran Abdulrahman Bokhari, Abdullah Alkhattabi, Saeed Alsharif, Mohannad Abdulrahman Aljehani, Abdulmalik Mohammed Alsabban, Mohammad Almtrafi, Ysear Abdulaziz Zakri, Abdullah AlMahmoud, Khalid Mohammed Alghamdi, Ahmed M Ashour & Nasser M Alorfi. (2024) Exploring Promising Therapies for Non-Alcoholic Fatty Liver Disease: A ClinicalTrials.gov Analysis. Diabetes, Metabolic Syndrome and Obesity 17, pages 545-561.
Read now

Articles from other publishers (2)

Letícia Grecco, Raphaela Nogueira Dutra, Nasser Fraga Muhammad & Alírio Caribé Ribeiro Neto. (2024) Semaglutida como coadjuvante para tratamento da Obesidade Infantil: uma revisão sistemática. Cuadernos de Educación y Desarrollo 16:2 Edição Especial.
Crossref
Congqin Chen, Rijing Zhou, Fang Fu & Jie Xiao. (2023) Postmarket safety profile of suicide/self-injury for GLP-1 receptor agonist: a real-world pharmacovigilance analysis. European Psychiatry 66:1.
Crossref